Shorter Telomeres May Mark Early Risk of Dementia: Preliminary Analysis of 62 Participants from the Nurses' Health Study

• Francine Grodstein ,

  *To whom correspondence should be addressed. E-mail: fgrodstein@partners.org

  Affiliations Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯
• Marieke van Oijen,

  Affiliations Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands, Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands

  ⨯
• Michael C. Irizarry,

  Affiliation Glaxo-Smith Kline, Research Triangle Park, North Carolina, United States of America

  ⨯
• H. Diana Rosas,

  Affiliation Massachusetts Alzheimer Disease Research Center, Massachusetts General Hospital, Department of Neurology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Bradley T. Hyman,

  Affiliation Massachusetts Alzheimer Disease Research Center, Massachusetts General Hospital, Department of Neurology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• John H. Growdon,

  Affiliation Massachusetts Alzheimer Disease Research Center, Massachusetts General Hospital, Department of Neurology, Harvard Medical School, Boston, Massachusetts, United States of America

  ⨯
• Immaculata De Vivo

  Affiliations Channing Laboratory, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts, United States of America, Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts, United States of America

  ⨯